Kidney Transplant Failure and RejectionNCT04202237
Using the Speckle Doppler to Quantify Blood Flow in Kidney and Pancreas Grafts
An observational study of Kidney Transplant Failure and Rejection, run by Manchester University NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Kidney Transplant Failure and Rejection
- What is being tested?
- Speckle Doppler imaging and Blood sample
- How many people
- 8 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 6 Dec 2019to 30 Jul 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study plans to recruit all recipients of, both kidney and pancreas transplants within a 14-week course of the study (Period of Lease of the Speckle Laser Doppler). It is expected that approximately n=60 kidney transplants (Living Donor, DBD and DCD and Marginal Kidneys) and n=8 pancreas transplant patients will be recruited in this study period. This will provide a range of grafts of varying quality of perfusion for assessment
Who may be able to join
- Kidney Transplant Recipients
- Age between 18 and 75 years
- English Speaking as no funding for translators available
- Able to provide written informed consent
- Receiving a kidney transplant at Manchester University NHS Foundation Trust
- Pancreas Transplant Recipients
Show all 9Show fewer
- Age between 18 and 75 years
- English Speaking as no funding for translators available
- Able to provide written informed consent All individuals will be considered for inclusion in this study regardless of age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion and belief, sex, and sexual orientation except where the study inclusion and exclusion criteria EXPLICITLY state otherwise.
Who cannot join
- Outside of stated age range. Aged 76+
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Manchester University NHS Foundationn Trust
Manchester, Greater Manchester, M13 9WL
About this study
Official title: Using the Speckle Doppler to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion
Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. The immediate determinant of the survival of any transplanted allograft often depends on the overall quality of perfusion of the organ. The assessment of perfusion is currently visually and empirically done and reported by the surgical team, with low objectivity. The Laser Speckle Doppler technique will be used in both kidney and pancreas transplantation to objectively study the quality of blood flow to the kidney and pancreas after transplantation. This Doppler will provide continuous, non-invasive blood flow monitoring of the microvascular environment of the transplanted organ. The strength of the technique is in evaluating changes in flow over an area of interest or the whole transplanted organ and accurately numerically quantifying the flow. The laser speckle Doppler technique is now well established and has been used in various clinical and research setting as the most convenient means of assessing tissue blood flow. It has however not yet been used in kidney and pancreas transplantation.
Read the detailed description
BACKGROUND After reperfusion in solid organ transplantation, the quality of organ reperfusion is often assessed visually and reported as good, moderate, reasonable, patchy or poor. In our centre a Renogram is usually performed which uses radioactive tracer which most kidney transplant recipients would have within 24 hours after transplantation to assess the overall perfusion of the allograft. The Speckle Laser Doppler is a powerful clinical tool to obtain full field, high resolution images of microvascular perfusion of an organ It has been used in many medical fields such as dermatology vascular medicine and neurosciences both in a research and in clinical settings. This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion.
The Speckle Laser Doppler blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting.
RESEARCH QUESTION/AIM(S)
- To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation and obtain real time video images with physical parametric data of the blood flow of transplanted organs at the time of transplantation as a proof of principle study to accurately quantify the blood flow rate either in the whole transplanted organ or a specific area of interest so as to develop a robust numerical quantification system of reporting on the perfusion of the transplanted organ. While this technique has been used in neurosurgery and other clinical settings it has not been evaluated before in a transplant setting. .
- Measure the markers of inflammation (Hypo perfusion) and oxidative stress and attempt correlation with the quality of perfusion obtained.
Objectives
This study aims to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion
Outcome Circulating markers of hypo perfusion and kidney injury will be measured to include: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress and assess their correlation with outputs from the two devices.
RATIONALE This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion.
The moorFLPI-2 blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting.
STUDY DESIGN and METHODS of DATA COLLECTION AND DATA ANALYIS Speckle Doppler The Speckle Laser Doppler blood flow imager will be used to obtain real-time blood flow images at reperfusion and immediately thereafter this imaging will occur immediately after the surgery when the patient is still under anaesthetic it will take approximately 15 minutes. Initially these images with the flow parametric data will be stored on a laptop which comes with the rental equipment. However once the study is complete, all images and data will be stored on a desktop/drive in the department along with other departmental research data confidentially. The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The Speckle Laser Doppler has two low power visible aiming lasers that indicate the approximate centre of the image. The aiming lasers will appear as a single point at a distance of 25 cm. As the distance is increased or decreased from 25 cm, the aiming lasers will appear as two separate points with the centre of the image being located at the midpoint between them. The aiming lasers can be turned on or off by pressing the button on the scan head or from the System Setup window in the PC software.
The moorFLPI-2 measurement software provides two measurement modes that can be used separately or in combination:
- Multi-image measurement mode.
- Single point measurement mode. The multi-image mode setting will be used as it measures flux over regular timed intervals and that is what is required for us to quantify the perfusion as compared to a single point measurement mode which measures the average flux at a single point in time.
Blood samples Concurrently blood samples will be obtained on each patient on Day 0 (day of transplantation), after reperfusion to measure markers of hypo perfusion and kidney injury: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress
Clinical Follow up
Patients will be monitored for 3 years following their transplant to look for any transplant related problems which may relate to the quality of the organ as assessed by speckle Doppler.
Sample size and Statistical analysis This is an exploratory study to evaluate the use of Doppler in kidney transplants and as such sample size is mainly dictated by pragmatic considerations and what is available for the duration of hiring the device. Nevertheless sample of 68 is sufficient to provide reasonable precision for the agreement and correlation tests intended for this study in an exploratory level. The analyses will be mainly descriptive. Tests will be exploratory and in the view of generating information for future larger studies.
Research Q1 The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The comparison between the 2 methods for measuring blood flow will be assessed for agreement using the appropriate statistical methodology.
The continuous variables for markers of inflammation, circulating markers of hypo perfusion and oxidative stress will also be assessed for any correlation with speckle Doppler perfusion measurements.
Events at the end of 3 years follow up will be compared with the blood flow measurements in categorical analysis.
STUDY SETTING Our unit performs the largest number of kidneys transplants in the UK so has access to a large number of samples for this project.
All members of the team have academic track records and participate in several on-going research projects. Current research projects are investigating cardiovascular disease, kidney perfusion, and MR imaging.
- Conditions
- Kidney Transplant Failure and Rejection
- Being tested
- Speckle Doppler imaging, Blood sample
- Medical subject headings
- Rejection, Psychology
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Speckle Doppler imagingOther
Also called Laser Imaging
Speckle Doppler Laser imaging
Blood sampleOther
Also called Venepuncture
Blood sampling
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation
Doppler imaging of kidneys and pancreas
Measured: 3 months
Secondary outcomes (1)
Measure the markers of inflammation ng/ml Hypo perfusion and oxidative stress (ng/ml) and attempt correlation with the quality of perfusion obtained
Circulating biomarkers of inflammation and oxidative stress
Measured: 6-12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Dec 2019
- Study start6 Dec 2019
- Primary completion30 Jul 2021
- Study completion30 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Kidney Transplant Failure and RejectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 8 participants (actual)
Sponsor and investigators
- Lead sponsor
- Manchester University NHS Foundation Trust
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Titus Augustine, FRCS, Principal investigator, Manchester university foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04202237
- Sponsor's protocol ID
- B00075
- Status last verified
- Oct 2021
- First submitted
- 11 Dec 2019
- Last updated
- 5 Oct 2021
- Results posted
- No
- FDA-regulated drug
- No
- Individual data sharing
- No
Publications
Gopal JP, Vaz O, Varley R, Spiers H, Goldsworthy MA, Siddagangaiah V, Lock B, Sharma V, Summers A, Moinuddin Z, van Dellen D, Augustine T. Using Laser Speckle Contrast Imaging to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion: A Proof-of-Principle Study. Transplant Direct. 2023 Apr 19;9(5):e1472. doi: 10.1097/TXD.0000000000001472. eCollection 2023 May.
PubMed 37090123
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using the Speckle Doppler to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion
- ClinicalTrials.gov ID
- NCT04202237
- Acronym / sponsor ID
- B00075
- Conditions
- Kidney Transplant Failure and Rejection
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 8 participants (actual)
- Lead sponsor
- Manchester University NHS Foundation TrustOther government
- Study start
- 6 Dec 2019 (actual)
- Primary completion
- 30 Jul 2021 (actual)
- Study completion
- 30 Jul 2021 (actual)
- First posted
- 17 Dec 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. The immediate determinant of the survival of any transplanted allograft often depends on the overall quality of perfusion of the organ. The assessment of perfusion is currently visually and empirically done and reported by the surgical team, with low objectivity. The Laser Speckle Doppler technique will be used in both kidney and pancreas transplantation to objectively study the quality of blood flow to the kidney and pancreas after transplantation. This Doppler will provide continuous, non-invasive blood flow monitoring of the microvascular environment of the transplanted organ. The strength of the technique is in evaluating changes in flow over an area of interest or the whole transplanted organ and accurately numerically quantifying the flow. The laser speckle Doppler technique is now well established and has been used in various clinical and research setting as the most convenient means of assessing tissue blood flow. It has however not yet been used in kidney and pancreas transplantation.
Detailed description
BACKGROUND After reperfusion in solid organ transplantation, the quality of organ reperfusion is often assessed visually and reported as good, moderate, reasonable, patchy or poor. In our centre a Renogram is usually performed which uses radioactive tracer which most kidney transplant recipients would have within 24 hours after transplantation to assess the overall perfusion of the allograft. The Speckle Laser Doppler is a powerful clinical tool to obtain full field, high resolution images of microvascular perfusion of an organ It has been used in many medical fields such as dermatology vascular medicine and neurosciences both in a research and in clinical settings. This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion.
The Speckle Laser Doppler blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting.
RESEARCH QUESTION/AIM(S)
- To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation and obtain real time video images with physical parametric data of the blood flow of transplanted organs at the time of transplantation as a proof of principle study to accurately quantify the blood flow rate either in the whole transplanted organ or a specific area of interest so as to develop a robust numerical quantification system of reporting on the perfusion of the transplanted organ. While this technique has been used in neurosurgery and other clinical settings it has not been evaluated before in a transplant setting. .
- Measure the markers of inflammation (Hypo perfusion) and oxidative stress and attempt correlation with the quality of perfusion obtained.
Objectives
This study aims to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion
Outcome Circulating markers of hypo perfusion and kidney injury will be measured to include: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress and assess their correlation with outputs from the two devices.
RATIONALE This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion.
The moorFLPI-2 blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting.
STUDY DESIGN and METHODS of DATA COLLECTION AND DATA ANALYIS Speckle Doppler The Speckle Laser Doppler blood flow imager will be used to obtain real-time blood flow images at reperfusion and immediately thereafter this imaging will occur immediately after the surgery when the patient is still under anaesthetic it will take approximately 15 minutes. Initially these images with the flow parametric data will be stored on a laptop which comes with the rental equipment. However once the study is complete, all images and data will be stored on a desktop/drive in the department along with other departmental research data confidentially. The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The Speckle Laser Doppler has two low power visible aiming lasers that indicate the approximate centre of the image. The aiming lasers will appear as a single point at a distance of 25 cm. As the distance is increased or decreased from 25 cm, the aiming lasers will appear as two separate points with the centre of the image being located at the midpoint between them. The aiming lasers can be turned on or off by pressing the button on the scan head or from the System Setup window in the PC software.
The moorFLPI-2 measurement software provides two measurement modes that can be used separately or in combination:
- Multi-image measurement mode.
- Single point measurement mode. The multi-image mode setting will be used as it measures flux over regular timed intervals and that is what is required for us to quantify the perfusion as compared to a single point measurement mode which measures the average flux at a single point in time.
Blood samples Concurrently blood samples will be obtained on each patient on Day 0 (day of transplantation), after reperfusion to measure markers of hypo perfusion and kidney injury: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress
Clinical Follow up
Patients will be monitored for 3 years following their transplant to look for any transplant related problems which may relate to the quality of the organ as assessed by speckle Doppler.
Sample size and Statistical analysis This is an exploratory study to evaluate the use of Doppler in kidney transplants and as such sample size is mainly dictated by pragmatic considerations and what is available for the duration of hiring the device. Nevertheless sample of 68 is sufficient to provide reasonable precision for the agreement and correlation tests intended for this study in an exploratory level. The analyses will be mainly descriptive. Tests will be exploratory and in the view of generating information for future larger studies.
Research Q1 The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The comparison between the 2 methods for measuring blood flow will be assessed for agreement using the appropriate statistical methodology.
The continuous variables for markers of inflammation, circulating markers of hypo perfusion and oxidative stress will also be assessed for any correlation with speckle Doppler perfusion measurements.
Events at the end of 3 years follow up will be compared with the blood flow measurements in categorical analysis.
STUDY SETTING Our unit performs the largest number of kidneys transplants in the UK so has access to a large number of samples for this project.
All members of the team have academic track records and participate in several on-going research projects. Current research projects are investigating cardiovascular disease, kidney perfusion, and MR imaging.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study plans to recruit all recipients of, both kidney and pancreas transplants within a 14-week course of the study (Period of Lease of the Speckle Laser Doppler). It is expected that approximately n=60 kidney transplants (Living Donor, DBD and DCD and Marginal Kidneys) and n=8 pancreas transplant patients will be recruited in this study period. This will provide a range of grafts of varying quality of perfusion for assessment
Key inclusion criteria (9 listed)
- Kidney Transplant Recipients
- Age between 18 and 75 years
- English Speaking as no funding for translators available
- Able to provide written informed consent
- Receiving a kidney transplant at Manchester University NHS Foundation Trust
Key exclusion criteria (1 listed)
- Outside of stated age range. Aged 76+
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Speckle Doppler imagingAlso: Laser ImagingSpeckle Doppler Laser imaging | Other | – |
| Blood sampleAlso: VenepunctureBlood sampling | Other | – |
Primary outcome
To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation
Time frame: 3 months
Doppler imaging of kidneys and pancreas
1 secondary outcome
Measure the markers of inflammation ng/ml Hypo perfusion and oxidative stress (ng/ml) and attempt correlation with the quality of perfusion obtained
Time frame: 6-12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2021.
- Derived from this study: PubMed 37090123Gopal JP, Vaz O, Varley R, Spiers H, Goldsworthy MA, Siddagangaiah V, Lock B, Sharma V, Summers A, Moinuddin Z, van Dellen D, Augustine T. Using Laser Speckle Contrast Imaging to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion: A Proof-of-Principle Study. Transplant Direct. 2023 Apr 19;9(5):e1472. doi: 10.1097/TXD.0000000000001472. eCollection 2023 May.
- Individual participant dataSharing planned: No
Related trials for Kidney Transplant Failure and Rejection
Not yet recruitingObservational study
Microbiota Changes Related to Outcomes in Kidney Transplantation
End-stage Renal Disease (ESRD), Kidney Transplantation
Recruiting
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection
Kidney Transplant Failure and Rejection
RecruitingPhase 2
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
Renal Transplant Failure and Rejection
Not yet recruitingPhase 3
Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
Kidney Transplant Rejection
Active, not recruitingPhase 4
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)
Kidney Transplant Failure and Rejection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Titus Augustine, FRCS principal investigator
Manchester university foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Kidney Transplant Failure and Rejection, run by Manchester University NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04202237, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2021.